Supplier profile
betapharm Arzneimittel GmbH
Every public-sector award we hold for this supplier, across Belgium, Germany, Denmark, Finland and Sweden, from 17 Apr 2009 to 12 Aug 2026.
Awards won
218
all time
Attributed value
€3.3m
200 shared, unvalued
Buyers
54
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 32 | not attributable |
| IKK classic | 31 | €491k |
| GWQ ServicePlus AG | 22 | not attributable |
| Techniker Krankenkasse | 18 | not attributable |
| AOK Nordost – Die Gesundheitskasse | 11 | not attributable |
| AOK Baden-Württemberg | 10 | not attributable |
| spectrumK GmbH | 8 | not attributable |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen; Stabsbereich Recht; Referat Zentrale Vergabestelle | 7 | not attributable |
| Vergabestelle der AOK – Rheinland-Pfalz/Saarland – Die Gesundheitskasse | 7 | not attributable |
| Barmer GEK | 5 | not attributable |
What they win
Awards
Showing 26–50 of 218 awards we hold
- Germany – Pharmaceutical products – Abschluss von Rabattverträgen gemäß § 130a Abs. 8 SGB V für Arzneimittel im generischen Markt ↗AOK Baden-Württembergshared awardawarded 5 Aug 2025
- Anastrozol ↗AOK Baden-Württembergshared awardawarded 4 Aug 2025
- Germany – Pharmaceutical products – Arzneimittelausschreibung 2025_vergebene Aufträge ↗IKK classicshared awardawarded 19 Jul 2025
- 001 | Abirateron Filmtabletten [3] ↗IKK classicshared awardawarded 18 Jul 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 3 Jul 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Denosumab, ATC M05BX04 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Jul 2025
- Germany – Pharmaceutical products – Generika-Ersatzkassen 24 ↗DAK-Gesundheitshared awardawarded 18 Jun 2025
- 101 - DAK / KKH - Acarbose - A10BF01 ↗DAK-Gesundheitshared awardawarded 17 Jun 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Sweden – Pharmaceutical products – Läkemedel Cytostatika 2025 ↗Region Blekingeshared awardawarded 24 May 2025
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 ↗PBMG eGawarded 29 Jan 2025
- Germany – Pharmaceutical products – 32. Generikaausschreibung (2;3er) - Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- Aripiprazol (LSE) ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ginkgo-biloba-Blätter-Trockenextrakt, ATC N06DP01 für die Zeit 01.01.2025 - 31.12.2026 ↗DAK-Gesundheitshared awardawarded 1 Jan 2025
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ginkgo-biloba-Blätter-Trockenextrakt, ATC N06DP01 für die Zeit 01.01.2025 - 31.12.2026 ↗DAK-Gesundheitshared awardawarded 1 Jan 2025
- Amlodipin ↗AOK Baden-Württembergshared awardawarded 30 Dec 2024
- Azelastin und Fluticason 17-propionat - TK, hkk, HEK (ATC-Code: R01AD28) ↗Techniker Krankenkasseshared awardawarded 23 Dec 2024
- Sweden – Pharmaceutical products – Läkemedel onkologi 2025 ↗Region Skåne, Koncernstab inköp och ekonomistyrningshared awardawarded 29 Nov 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bosutinib, ATC L01EA04 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bosutinib, ATC L01EA04 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 1 Oct 2024
- 101 - DAK / KKH - Colecalciferol - A11CC05 (TEI) ↗DAK-Gesundheitshared awardawarded 10 Sept 2024
- Germany – Pharmaceutical products – Generika-Ersatzkassen 20 ↗DAK-Gesundheitshared awardawarded 31 Aug 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 22 Aug 2024
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.